Metabolon, a diagnostics and services company offering biochemical profiling technology, has raised $13.1 million in a series D financing round. Existing investors, including Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght and Fulcrum Financial Partners, participated in the round. New investor Keating Capital also took part. The company will use the proceeds to support the further expansion of its Metabolytics division and ongoing development of its oncology diagnostics product portfolio.
Click here for the release from Business Wire.